Compare ICUI & CNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ICUI | CNS |
|---|---|---|
| Founded | 1984 | 1986 |
| Country | United States | United States |
| Employees | N/A | 424 |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 4.0B |
| IPO Year | 1995 | 2004 |
| Metric | ICUI | CNS |
|---|---|---|
| Price | $154.42 | $77.40 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $169.00 | $71.50 |
| AVG Volume (30 Days) | 282.9K | ★ 309.1K |
| Earning Date | 05-07-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 3.96% |
| EPS Growth | ★ 100.62 | N/A |
| EPS | ★ 1.20 | 0.82 |
| Revenue | ★ $2,231,262,000.00 | $427,536,000.00 |
| Revenue This Year | N/A | $4.71 |
| Revenue Next Year | $4.46 | $4.37 |
| P/E Ratio | $130.43 | ★ $93.78 |
| Revenue Growth | N/A | ★ 4.07 |
| 52 Week Low | $107.02 | $58.39 |
| 52 Week High | $162.18 | $80.48 |
| Indicator | ICUI | CNS |
|---|---|---|
| Relative Strength Index (RSI) | 61.90 | 57.28 |
| Support Level | $146.59 | $59.88 |
| Resistance Level | $160.09 | $78.69 |
| Average True Range (ATR) | 5.17 | 2.10 |
| MACD | 0.51 | -0.12 |
| Stochastic Oscillator | 72.06 | 64.77 |
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests primarily in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for nearly two-thirds of its $99.5 billion in managed assets at the end of May 2026. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 39% (25%) of its managed assets (base management fees) from institutional clients, 48% (55%) from open-end funds, and 13% (20%) from closed-end funds.